Navigation Links
Empire Blue Cross Blue Shield Awarded NCQA's Accreditation Status of 'Excellent'
Date:9/1/2009

NEW YORK, Sept. 1 /PRNewswire/ -- Empire BlueCross BlueShield announced today that it has been awarded the accreditation status of "Excellent" for its HMO Commercial HMO/POS Combined and Medicare HMO products from the National Committee for Quality Assurance (NCQA). Empire's accreditation status - the highest possible level - is based on a voluntary review of how a health plan ensures that its members receive access to high quality care.

"NCQA's Excellent Accreditation status is reserved for the best health plans in the nation. It is only awarded to those plans that meet or exceed NCQA's rigorous requirements for consumer protection and quality improvement and deliver excellent clinical care," said Margaret E. O'Kane, president of NCQA. "It is partly a health plan's members that determine whether it earns NCQA's Excellent Accreditation status. Any plan that does so should be proud of its accomplishment. It is a sign that the plan's delivering great service and great care -- it's met the toughest test in managed care."

NCQA is an independent, non-profit organization that is dedicated to assessing and reporting on the quality of managed care plans, managed behavioral healthcare organizations, preferred provider organizations, new health plans, physician organizations, credentials verification organizations, disease management programs and other health-related programs.

The NCQA Health Plan Accreditation surveys include rigorous on-site and off-site evaluations of over 60 standards and selected HEDIS measures. A team of physicians and health plan experts conducts accreditation surveys. A national oversight committee of physicians analyzes the team's findings and assigns an accreditation level based on the performance level of each plan being evaluated to NCQA's standards.

"For the last 75 years, Empire has maintained a long and proud tradition of providing access to high quality care - it is an honor being validated by NCQA. Every one of our more than 4,000 employees and our participating network physicians and hospitals contribute to the NCQA Accreditation process in some way, so we are extremely proud of this achievement," said Mark Wagar, president and CEO, Empire BlueCross BlueShield. "This accreditation tells our members that the care coverage they receive and the physicians who provide that care constantly maintain high standards of quality."

Empire BlueCross BlueShield, a leading provider of health insurance in New York since 1934, is celebrating it's 75th Anniversary this year. Today, Empire BlueCross BlueShield proudly provides health care benefits to nearly 6 million members and access to an extensive network of doctors and hospitals with the strength, stability, and national recognition of the Blue Cross and Blue Shield brand. You can learn more at www.empireblue.com.

(R) HEDIS is a registered trademark of NCQA.

About Empire Blue Cross Blue Shield

Empire Blue Cross Blue Shield (Empire) is the trade name of Empire HealthChoice Assurance, Inc., and Empire Blue Cross Blue Shield HMO is the trade name of Empire HealthChoice HMO, Inc., independent licensees of the Blue Cross Blue Shield Association, serving residents and businesses in the 28 eastern and southeastern counties of New York State. Additional information about Empire is available at www.empireblue.com.


'/>"/>
SOURCE Empire BlueCross BlueShield
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Assured Pharmacy Retains Empire Financial Group
2. New Empire BlueCross BlueShield Prism Plans Offer Better Choice and Affordability for New York Small Group Market
3. Empire BlueCross BlueShield Announces Release of State Health Index Data
4. Empire BlueCross BlueShield and New York Attorney General Reach Agreement on Guidelines for State Doctor Ranking Programs
5. Loma Linda University Medical Center Celebrates Groundbreaking on Inland Empires Most Comprehensive Rehabilitation Center
6. Empire Blue Cross Blue Shield Statement in Response to New York Attorney Generals Recent Subpoenas
7. Empire Blue Cross Blue Shield Announces Initiative to Protect Members Health Aimed at Preventing Serious Medical Errors
8. Empire BlueCross BlueShield Associates Commit Over $1 Million to Community Organizations in 2008
9. Empire BlueCross BlueShield Appoints Chief Medical Officer
10. Taking Action Together Aims to Increase Screenings and Offer Education to People with Diabetes Living in the Inland Empire
11. Hilary Duff to Light Empire State Building Commemorating 24th Annual AIDS Walk New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... , ... IndustryArchive.Org . is announcing a new way for B2B Sellers ... only pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase ... reality that B2B buyers are controlling the sales process via the Internet and that ...
(Date:2/26/2017)... ... , ... ODH, Inc.™ announced today it will exhibit and speak at ... Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present ... population health management. , ODH will also have an exhibit booth where attendees may ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure ... a specific LRRK2 mutation, according to a study released today at the 1st ... of a link between pesticides and incidence of sporadic PD through occupational exposure. ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... its newly designed TaskMate Go. Core benefits and advantages built into the home ... a stylish, functional look and feel. Ability to gain the benefits embedded in ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the ... Market (ILTM) show in Cannes (France), XO Private has initiated a second print-run of ... book measures almost a metre across when open, weighs in at more than six ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
(Date:2/24/2017)... Wyoming , Feb. 24, 2017  Xynomic Pharmaceuticals, ... today announced that it has acquired exclusive worldwide ... potentially best-in-class innovative HDAC inhibitor targeting hematological and ... of 14 Phase 1 and 2 clinical trials ... Asia have already been completed, demonstrating ...
Breaking Medicine Technology: